Data as of Apr 17
| +0.03 / +0.99%|
The 4 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 6.25, with a high estimate of 6.50 and a low estimate of 6.00. The median estimate represents a +103.58% increase from the last price of 3.07.
The current consensus among 4 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.